Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Oct 18;36(11):2883-2890.
doi: 10.1093/humrep/deab218.

Outcomes of SARS-CoV-2 infected pregancies after medically assisted reproduction

ESHRE COVID-19 Working Group; Baris Ata  1 , Luca Gianaroli  2 , Kersti Lundin  3 , Saria Mcheik  4 , Edgar Mocanu  5 , Satu Rautakallio-Hokkanen  6 , Juha S Tapanainen  7   8 , Nathalie Vermeulen  4 , Anna Veiga  9
Collaborators, Affiliations

Outcomes of SARS-CoV-2 infected pregancies after medically assisted reproduction

ESHRE COVID-19 Working Group et al. Hum Reprod. .

Abstract

Study question: What is the impact of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection on the outcome of a pregnancy after medically assisted reproduction (MAR)?

Summary answer: Our results suggest that MAR pregnancies are not differentially affected by SARS-CoV-2 infection compared to spontaneous pregnancies.

What is known already: Information on the effects of coronavirus disease 2019 (COVID-19) on pregnancy after MAR is scarce when women get infected during MAR or early pregnancy, even though such information is vital for informing women seeking pregnancy.

Study design, size, duration: Data from SARS-CoV-2 affected MAR pregnancies were collected between May 2020 and June 2021 through a voluntary data collection, organised by the European Society of Human Reproduction and Embryology (ESHRE).

Participants/materials, setting, methods: All ESHRE members were invited to participate to an online data collection for SARS-CoV-2-infected MAR pregnancies.

Main results and the role of chance: The dataset includes 80 cases from 32 countries, including 67 live births, 10 miscarriages, 2 stillbirths and 1 maternal death. An additional 25pregnancies were ongoing at the time of writing.

Limitations, reasons for caution: An international data registry based on voluntary contribution can be subject to selective reporting with possible risks of over- or under-estimation.

Wider implications of the findings: The current data can be used to guide clinical decisions in the care of women pregnant after MAR, in the context of the COVID-19 pandemic.

Study funding/competing interest(s): The authors acknowledge the support of ESHRE for the data registry and meetings. J.S.T. reports grants or contracts from Sigrid Juselius Foundation, EU and Helsinki University Hospital Funds, outside the scope of the current work. The other authors declare that they have no conflict of interest.

Trial registration number: N/A.

Keywords: COVID-19; ESHRE; IVF; SARS-CoV-2; medically assisted reproduction; pregnancy.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Overview of data entries to final dataset. 1cases excluded from the final dataset included 52 cases that could not yet be validated, and 6 cases with incomplete data on delivery.
Figure 2.
Figure 2.
Countries (in blue) represented within the final dataset (80 cases and 25 ongoing pregnancies).
See this image and copyright information in PMC

References

    1. Allotey J, Stallings E, Bonet M, Yap M, Chatterjee S, Kew T, Debenham L, Llavall AC, Dixit A, Zhou D. et al.; for PregCOV-19 Living Systematic Review Consortium. Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis. BMJ 2020;370:m3320. - PMC - PubMed
    1. Berntsen S, Söderström-Anttila V, Wennerholm UB, Laivuori H, Loft A, Oldereid NB, Romundstad LB, Bergh C, Pinborg A.. The health of children conceived by ART: ‘the chicken or the egg?’. Hum Reprod Update 2019;25:137–158. - PubMed
    1. Engels Calvo V, Cruz Melguizo S, Abascal-Saiz A, Forcén Acebal L, Sánchez-Migallón A, Pintado Recarte P, Cuenca Marín C, Marcos Puig B, Del Barrio Fernández PG, Nieto Velasco O. et al.; Spanish Obstetric Emergency Group. Perinatal outcomes of pregnancies resulting from assisted reproduction technology in SARS-CoV-2-infected women: a prospective observational study. Fertil Steril 2021;116:731–740. - PMC - PubMed
    1. Gianaroli L, Ata B, Lundin K, Rautakallio-Hokkanen S, Tapanainen JS, Vermeulen N, Veiga A, Mocanu E; ESHRE COVID-19 Working Group. The calm after the storm: re-starting ART treatments safely in the wake of the COVID-19 pandemic. Hum Reprod 2021;36:275–282. - PMC - PubMed
    1. Mark EG, McAleese S, Golden WC, Gilmore MM, Sick-Samuels A, Curless MS, Nogee LM, Milstone AM, Johnson J.. Coronavirus disease 2019 in pregnancy and outcomes among pregnant women and neonates: a literature review. Pediatr Infect Dis J 2021;40:473–478. - PMC - PubMed

Publication types

Grants and funding